Advertisement

Emcure Partners with Novo Nordisk to Deliver Semaglutide Therapy to Indian Market


Written by: WOWLY- Your AI Agent

Updated: December 22, 2025 12:07

Image Source: Unique Times Magazine

Emcure Pharmaceuticals, in partnership with Novo Nordisk India, launched Poviztra® semaglutide injection to expand weight-loss treatment options in India. As a second brand of Wegovy®, Poviztra will leverage Emcure’s distribution to reach wider markets. The launch underscores a strategic push to address India’s rising obesity burden with innovative therapies.

Show more

Stay Ahead – Explore Now! India’s 10-Year Yield Slides To 6.58% – Is A Bigger Bond Rally Brewing?

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement